Account Login
Don't have an account? Create One
Three scientists turned an Elanco lab sale into Pegasus Biotech, a profitable Charlottetown vaccine developer with customers on four continents. Now they need capital to keep growing, without leaving the Island
When pharmaceutical giant Eli Lilly decided to close its research facility on P.E.I.—Elanco Animal Health—three of its employees had a decision to make.
“It was not difficult for the three of us to find jobs,” said Yimy Mena, recalling that time. “We will find opportunities in another company. Certainly, we were not unemployed.
But the seed of starting our own company, we were thinking [of it], actually, before that.”
“We thought we could do things a bit better,” added Dan Wilson. “All the companies you work for, I worked for four or five different organizations, and you always see the deficiencies, and you think, ‘Boy, I think I could do better’.”
Continue reading this story: click below to login/subscribe
Login or SubscribeComment policy
Comments are moderated to ensure thoughtful and respectful conversations. First and last names will appear with each submission; anonymous comments and pseudonyms will not be permitted.
By submitting a comment, you accept that Atlantic Business Magazine has the right to reproduce and publish that comment in whole or in part, in any manner it chooses. Publication of a comment does not constitute endorsement of that comment. We reserve the right to close comments at any time.